<p>The classifier rules for venetoclax containing combination drugs.</p>
收藏NIAID Data Ecosystem2026-05-10 收录
数据链接：
官方服务：
资源简介：
The classifier rules for venetoclax containing combination drugs.
应用场景：
创建时间：
2026-02-23
相关数据集
ALL06 A Phase II trial of an intensive pediatric protocol incorporating post-induction stratification based on minimal residual disease levels for the treatment of adolescents aged 15 years and above, and young adults aged up to 40 years, with newly diagnosed acute lymphoblastic leukaemia (ALL)
Dataset includes: Data for 86 patients aged 15-40 years with newly diagnosed Acute Lymphoblastic Leukaemia. Modified form of BRM-2000 protocol in the 15-40 age group. Complete remission, disease-free
Research Data Australia90
Data Set for Retrospective cohort study monitoring Pegaspargase activity in acute lymphoblastic leukemia patients with and without premedication Lossaso M, Messinger Y, Bostrom B
Data from children and young adults with acute lymphoblastic leukemia receiving pegaspargase with and without premedications given to prevent high grade allergic reactions including anaphylaxis. Date
DataCite Commons2020-08-27 更新50
Gene expression analysis of previously treated hormone receptor-positive metastatic breast cancer. Gene expression analysis of previously treated hormone receptor-positive metastatic breast cancer
A large-panel gene expression analysis was conducted to identify biomarkers associated with the effectiveness of adding palbociclib to fulvestrant Overall design: Baseline tumor tissue from PALOMA-3 t
NIAID Data Ecosystem40
Data Set for Retrospective cohort study monitoring Pegaspargase activity in acute lymphoblastic leukemia patients with and without premedication Lossaso M, Messinger Y, Bostrom B
Data from children and young adults with acute lymphoblastic leukemia receiving pegaspargase with and without premedications given to prevent high grade allergic reactions including anaphylaxis. Date
DataCite Commons2020-09-20 更新70
Highly selective HSP90 inhibitor, pimitespib, demonstrates its potent growth suppressive activity to adult T-cell leukemia in preclinical models (Pt1-3).. Highly selective HSP90 inhibitor, pimitespib, demonstrates its potent growth suppressive activity to adult T-cell leukemia in preclinical models (Pt1-3).
Adult T-cell leukaemia-lymphoma (ATL) is a highly chemoresistant malignancy of peripheral T lymphocytes caused by human T-lymphotropic virus type I (HTLV-1). ATL cells constitutively activate anti-apo
NIAID Data Ecosystem40
